Click for best price
AL Amyloidosis Therapeutics Market Size, Share 2024
The global AL Amyloidosis Therapeutics market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Chemotherapy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of AL Amyloidosis Therapeutics include Janssen Pharmaceutical, Prothena, Alexion Pharmaceuticals, Oncopeptides AB, Bristol-Myers Squibb, GlaxoSmithKline Pharmaceuticals Ltd, Eidos Therapeutics, Inc., Corino Therapeutics, Inc. and Spectrum Pharmaceuticals, Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
The most common kind of systemic amyloidosis is the amyloid light chain (AL) amyloidosis, sometimes referred to as primary amyloidosis. Systemic light-chain (AL) amyloidosis was once thought to be an unstoppable deadly condition.
This report aims to provide a comprehensive presentation of the global market for AL Amyloidosis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AL Amyloidosis Therapeutics. This report contains market size and forecasts of AL Amyloidosis Therapeutics in global, including the following market information:
Global AL Amyloidosis Therapeutics Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the AL Amyloidosis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global AL Amyloidosis Therapeutics Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global AL Amyloidosis Therapeutics Market Segment Percentages, by Type, 2023 (%)
Chemotherapy
Supportive Care
Surgery
Stem Cell Transplant
Targeted Therapy
Global AL Amyloidosis Therapeutics Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global AL Amyloidosis Therapeutics Market Segment Percentages, by Application, 2023 (%)
Hospitals
Clinics
Ambulatory Service Centres
Others
Global AL Amyloidosis Therapeutics Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global AL Amyloidosis Therapeutics Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies AL Amyloidosis Therapeutics revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies AL Amyloidosis Therapeutics revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Janssen Pharmaceutical
Prothena
Alexion Pharmaceuticals
Oncopeptides AB
Bristol-Myers Squibb
GlaxoSmithKline Pharmaceuticals Ltd
Eidos Therapeutics, Inc.
Corino Therapeutics, Inc.
Spectrum Pharmaceuticals, Inc.
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of AL Amyloidosis Therapeutics, market overview.
Chapter 2: Global AL Amyloidosis Therapeutics market size in revenue.
Chapter 3: Detailed analysis of AL Amyloidosis Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of AL Amyloidosis Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
AL Amyloidosis Therapeutics Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 AL Amyloidosis Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global AL Amyloidosis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global AL Amyloidosis Therapeutics Overall Market Size
2.1 Global AL Amyloidosis Therapeutics Market Size: 2023 VS 2030
2.2 Global AL Amyloidosis Therapeutics Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top AL Amyloidosis Therapeutics Players in Global Market
3.2 Top Global AL Amyloidosis Therapeutics Companies Ranked by Revenue
3.3 Global AL Amyloidosis Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 AL Amyloidosis Therapeutics Companies in Global Market, by Revenue in 2023
3.5 Global Companies AL Amyloidosis Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 AL Amyloidosis Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 AL Amyloidosis Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 AL Amyloidosis Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global AL Amyloidosis Therapeutics Market Size Markets, 2023 & 2030
4.1.2 Chemotherapy
4.1.3 Supportive Care
4.1.4 Surgery
4.1.5 Stem Cell Transplant
4.1.6 Targeted Therapy
4.2 By Type - Global AL Amyloidosis Therapeutics Revenue & Forecasts
4.2.1 By Type - Global AL Amyloidosis Therapeutics Revenue, 2019-2024
4.2.2 By Type - Global AL Amyloidosis Therapeutics Revenue, 2025-2030
4.2.3 By Type - Global AL Amyloidosis Therapeutics Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global AL Amyloidosis Therapeutics Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Ambulatory Service Centres
5.1.5 Others
5.2 By Application - Global AL Amyloidosis Therapeutics Revenue & Forecasts
5.2.1 By Application - Global AL Amyloidosis Therapeutics Revenue, 2019-2024
5.2.2 By Application - Global AL Amyloidosis Therapeutics Revenue, 2025-2030
5.2.3 By Application - Global AL Amyloidosis Therapeutics Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global AL Amyloidosis Therapeutics Market Size, 2023 & 2030
6.2 By Region - Global AL Amyloidosis Therapeutics Revenue & Forecasts
6.2.1 By Region - Global AL Amyloidosis Therapeutics Revenue, 2019-2024
6.2.2 By Region - Global AL Amyloidosis Therapeutics Revenue, 2025-2030
6.2.3 By Region - Global AL Amyloidosis Therapeutics Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America AL Amyloidosis Therapeutics Revenue, 2019-2030
6.3.2 US AL Amyloidosis Therapeutics Market Size, 2019-2030
6.3.3 Canada AL Amyloidosis Therapeutics Market Size, 2019-2030
6.3.4 Mexico AL Amyloidosis Therapeutics Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe AL Amyloidosis Therapeutics Revenue, 2019-2030
6.4.2 Germany AL Amyloidosis Therapeutics Market Size, 2019-2030
6.4.3 France AL Amyloidosis Therapeutics Market Size, 2019-2030
6.4.4 U.K. AL Amyloidosis Therapeutics Market Size, 2019-2030
6.4.5 Italy AL Amyloidosis Therapeutics Market Size, 2019-2030
6.4.6 Russia AL Amyloidosis Therapeutics Market Size, 2019-2030
6.4.7 Nordic Countries AL Amyloidosis Therapeutics Market Size, 2019-2030
6.4.8 Benelux AL Amyloidosis Therapeutics Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia AL Amyloidosis Therapeutics Revenue, 2019-2030
6.5.2 China AL Amyloidosis Therapeutics Market Size, 2019-2030
6.5.3 Japan AL Amyloidosis Therapeutics Market Size, 2019-2030
6.5.4 South Korea AL Amyloidosis Therapeutics Market Size, 2019-2030
6.5.5 Southeast Asia AL Amyloidosis Therapeutics Market Size, 2019-2030
6.5.6 India AL Amyloidosis Therapeutics Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America AL Amyloidosis Therapeutics Revenue, 2019-2030
6.6.2 Brazil AL Amyloidosis Therapeutics Market Size, 2019-2030
6.6.3 Argentina AL Amyloidosis Therapeutics Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa AL Amyloidosis Therapeutics Revenue, 2019-2030
6.7.2 Turkey AL Amyloidosis Therapeutics Market Size, 2019-2030
6.7.3 Israel AL Amyloidosis Therapeutics Market Size, 2019-2030
6.7.4 Saudi Arabia AL Amyloidosis Therapeutics Market Size, 2019-2030
6.7.5 UAE AL Amyloidosis Therapeutics Market Size, 2019-2030
7 AL Amyloidosis Therapeutics Companies Profiles
7.1 Janssen Pharmaceutical
7.1.1 Janssen Pharmaceutical Company Summary
7.1.2 Janssen Pharmaceutical Business Overview
7.1.3 Janssen Pharmaceutical AL Amyloidosis Therapeutics Major Product Offerings
7.1.4 Janssen Pharmaceutical AL Amyloidosis Therapeutics Revenue in Global Market (2019-2024)
7.1.5 Janssen Pharmaceutical Key News & Latest Developments
7.2 Prothena
7.2.1 Prothena Company Summary
7.2.2 Prothena Business Overview
7.2.3 Prothena AL Amyloidosis Therapeutics Major Product Offerings
7.2.4 Prothena AL Amyloidosis Therapeutics Revenue in Global Market (2019-2024)
7.2.5 Prothena Key News & Latest Developments
7.3 Alexion Pharmaceuticals
7.3.1 Alexion Pharmaceuticals Company Summary
7.3.2 Alexion Pharmaceuticals Business Overview
7.3.3 Alexion Pharmaceuticals AL Amyloidosis Therapeutics Major Product Offerings
7.3.4 Alexion Pharmaceuticals AL Amyloidosis Therapeutics Revenue in Global Market (2019-2024)
7.3.5 Alexion Pharmaceuticals Key News & Latest Developments
7.4 Oncopeptides AB
7.4.1 Oncopeptides AB Company Summary
7.4.2 Oncopeptides AB Business Overview
7.4.3 Oncopeptides AB AL Amyloidosis Therapeutics Major Product Offerings
7.4.4 Oncopeptides AB AL Amyloidosis Therapeutics Revenue in Global Market (2019-2024)
7.4.5 Oncopeptides AB Key News & Latest Developments
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Company Summary
7.5.2 Bristol-Myers Squibb Business Overview
7.5.3 Bristol-Myers Squibb AL Amyloidosis Therapeutics Major Product Offerings
7.5.4 Bristol-Myers Squibb AL Amyloidosis Therapeutics Revenue in Global Market (2019-2024)
7.5.5 Bristol-Myers Squibb Key News & Latest Developments
7.6 GlaxoSmithKline Pharmaceuticals Ltd
7.6.1 GlaxoSmithKline Pharmaceuticals Ltd Company Summary
7.6.2 GlaxoSmithKline Pharmaceuticals Ltd Business Overview
7.6.3 GlaxoSmithKline Pharmaceuticals Ltd AL Amyloidosis Therapeutics Major Product Offerings
7.6.4 GlaxoSmithKline Pharmaceuticals Ltd AL Amyloidosis Therapeutics Revenue in Global Market (2019-2024)
7.6.5 GlaxoSmithKline Pharmaceuticals Ltd Key News & Latest Developments
7.7 Eidos Therapeutics, Inc.
7.7.1 Eidos Therapeutics, Inc. Company Summary
7.7.2 Eidos Therapeutics, Inc. Business Overview
7.7.3 Eidos Therapeutics, Inc. AL Amyloidosis Therapeutics Major Product Offerings
7.7.4 Eidos Therapeutics, Inc. AL Amyloidosis Therapeutics Revenue in Global Market (2019-2024)
7.7.5 Eidos Therapeutics, Inc. Key News & Latest Developments
7.8 Corino Therapeutics, Inc.
7.8.1 Corino Therapeutics, Inc. Company Summary
7.8.2 Corino Therapeutics, Inc. Business Overview
7.8.3 Corino Therapeutics, Inc. AL Amyloidosis Therapeutics Major Product Offerings
7.8.4 Corino Therapeutics, Inc. AL Amyloidosis Therapeutics Revenue in Global Market (2019-2024)
7.8.5 Corino Therapeutics, Inc. Key News & Latest Developments
7.9 Spectrum Pharmaceuticals, Inc.
7.9.1 Spectrum Pharmaceuticals, Inc. Company Summary
7.9.2 Spectrum Pharmaceuticals, Inc. Business Overview
7.9.3 Spectrum Pharmaceuticals, Inc. AL Amyloidosis Therapeutics Major Product Offerings
7.9.4 Spectrum Pharmaceuticals, Inc. AL Amyloidosis Therapeutics Revenue in Global Market (2019-2024)
7.9.5 Spectrum Pharmaceuticals, Inc. Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer AL Amyloidosis Therapeutics Major Product Offerings
7.10.4 Pfizer AL Amyloidosis Therapeutics Revenue in Global Market (2019-2024)
7.10.5 Pfizer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. AL Amyloidosis Therapeutics Market Opportunities & Trends in Global Market
Table 2. AL Amyloidosis Therapeutics Market Drivers in Global Market
Table 3. AL Amyloidosis Therapeutics Market Restraints in Global Market
Table 4. Key Players of AL Amyloidosis Therapeutics in Global Market
Table 5. Top AL Amyloidosis Therapeutics Players in Global Market, Ranking by Revenue (2023)
Table 6. Global AL Amyloidosis Therapeutics Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global AL Amyloidosis Therapeutics Revenue Share by Companies, 2019-2024
Table 8. Global Companies AL Amyloidosis Therapeutics Product Type
Table 9. List of Global Tier 1 AL Amyloidosis Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 AL Amyloidosis Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - AL Amyloidosis Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - AL Amyloidosis Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - AL Amyloidosis Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - AL Amyloidosis Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global AL Amyloidosis Therapeutics Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global AL Amyloidosis Therapeutics Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2025-2030
Table 30. Janssen Pharmaceutical Company Summary
Table 31. Janssen Pharmaceutical AL Amyloidosis Therapeutics Product Offerings
Table 32. Janssen Pharmaceutical AL Amyloidosis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 33. Janssen Pharmaceutical Key News & Latest Developments
Table 34. Prothena Company Summary
Table 35. Prothena AL Amyloidosis Therapeutics Product Offerings
Table 36. Prothena AL Amyloidosis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 37. Prothena Key News & Latest Developments
Table 38. Alexion Pharmaceuticals Company Summary
Table 39. Alexion Pharmaceuticals AL Amyloidosis Therapeutics Product Offerings
Table 40. Alexion Pharmaceuticals AL Amyloidosis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 41. Alexion Pharmaceuticals Key News & Latest Developments
Table 42. Oncopeptides AB Company Summary
Table 43. Oncopeptides AB AL Amyloidosis Therapeutics Product Offerings
Table 44. Oncopeptides AB AL Amyloidosis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 45. Oncopeptides AB Key News & Latest Developments
Table 46. Bristol-Myers Squibb Company Summary
Table 47. Bristol-Myers Squibb AL Amyloidosis Therapeutics Product Offerings
Table 48. Bristol-Myers Squibb AL Amyloidosis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 49. Bristol-Myers Squibb Key News & Latest Developments
Table 50. GlaxoSmithKline Pharmaceuticals Ltd Company Summary
Table 51. GlaxoSmithKline Pharmaceuticals Ltd AL Amyloidosis Therapeutics Product Offerings
Table 52. GlaxoSmithKline Pharmaceuticals Ltd AL Amyloidosis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 53. GlaxoSmithKline Pharmaceuticals Ltd Key News & Latest Developments
Table 54. Eidos Therapeutics, Inc. Company Summary
Table 55. Eidos Therapeutics, Inc. AL Amyloidosis Therapeutics Product Offerings
Table 56. Eidos Therapeutics, Inc. AL Amyloidosis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 57. Eidos Therapeutics, Inc. Key News & Latest Developments
Table 58. Corino Therapeutics, Inc. Company Summary
Table 59. Corino Therapeutics, Inc. AL Amyloidosis Therapeutics Product Offerings
Table 60. Corino Therapeutics, Inc. AL Amyloidosis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 61. Corino Therapeutics, Inc. Key News & Latest Developments
Table 62. Spectrum Pharmaceuticals, Inc. Company Summary
Table 63. Spectrum Pharmaceuticals, Inc. AL Amyloidosis Therapeutics Product Offerings
Table 64. Spectrum Pharmaceuticals, Inc. AL Amyloidosis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 65. Spectrum Pharmaceuticals, Inc. Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer AL Amyloidosis Therapeutics Product Offerings
Table 68. Pfizer AL Amyloidosis Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 69. Pfizer Key News & Latest Developments
List of Figures
Figure 1. AL Amyloidosis Therapeutics Segment by Type in 2023
Figure 2. AL Amyloidosis Therapeutics Segment by Application in 2023
Figure 3. Global AL Amyloidosis Therapeutics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global AL Amyloidosis Therapeutics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global AL Amyloidosis Therapeutics Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by AL Amyloidosis Therapeutics Revenue in 2023
Figure 8. By Type - Global AL Amyloidosis Therapeutics Revenue Market Share, 2019-2030
Figure 9. By Application - Global AL Amyloidosis Therapeutics Revenue Market Share, 2019-2030
Figure 10. By Type - Global AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global AL Amyloidosis Therapeutics Revenue Market Share, 2019-2030
Figure 12. By Application - Global AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global AL Amyloidosis Therapeutics Revenue Market Share, 2019-2030
Figure 14. By Region - Global AL Amyloidosis Therapeutics Revenue Market Share, 2019-2030
Figure 15. By Country - North America AL Amyloidosis Therapeutics Revenue Market Share, 2019-2030
Figure 16. US AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 17. Canada AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe AL Amyloidosis Therapeutics Revenue Market Share, 2019-2030
Figure 20. Germany AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 21. France AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 23. Italy AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 24. Russia AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia AL Amyloidosis Therapeutics Revenue Market Share, 2019-2030
Figure 28. China AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 29. Japan AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 32. India AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America AL Amyloidosis Therapeutics Revenue Market Share, 2019-2030
Figure 34. Brazil AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa AL Amyloidosis Therapeutics Revenue Market Share, 2019-2030
Figure 37. Turkey AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 38. Israel AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 40. UAE AL Amyloidosis Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 41. Janssen Pharmaceutical AL Amyloidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Prothena AL Amyloidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Alexion Pharmaceuticals AL Amyloidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Oncopeptides AB AL Amyloidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Bristol-Myers Squibb AL Amyloidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. GlaxoSmithKline Pharmaceuticals Ltd AL Amyloidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Eidos Therapeutics, Inc. AL Amyloidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Corino Therapeutics, Inc. AL Amyloidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Spectrum Pharmaceuticals, Inc. AL Amyloidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Pfizer AL Amyloidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
